Efficacy of adjuvant use of midodrine in patients with septic shock: An open label randomized controlled trial
The findings did not demonstrate a significant reduction in mortality with adjuvant midodrine use in the treatment of septic shock. Midodrine appears to reduce the need for vasopressors. However, our findings did not support that midodrine shortens the duration of vasopressor use nor the course of hospitalization for patients with septic shock.
Authors
- Moetaza M. Soliman (ORCID: https://orcid.org/0000-0002-8651-9385)
- Adel Al‐Hady Ahmed Diab
- Noha O. Mansour (ORCID: https://orcid.org/0000-0002-4448-994X)
- Nadine K. El‐Nagdy
Institutions
- Mansoura University (EG)
- Al-Azhar University (EG)
- Delta University for Science and Technology (EG)
Publication Details
- Journal
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1002/phar.70018
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00